Similar articles

• Insights on the pathogenicity of human T-lymphotropic/leukemia virus types I and II.

  Cereseto A, Mulloy JC, Franchini G. Cereseto A, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13 Suppl 1:S69-75. doi: 10.1097/00042560-199600001-00013. J Acquir Immune Defic Syndr Hum Retrovirol. 1996. PMID: 8797707 Review.
• Detection and characterization of human T-lymphotropic viruses.

  Calabrò ML, Favero A, Chieco-Bianchi L. Calabrò ML, et al. Antibiot Chemother (1971). 1994;46:125-33. doi: 10.1159/000423640. Antibiot Chemother (1971). 1994. PMID: 7826033 Review. No abstract available.
• [HTLV-I and HTLV-II virus].

  Maniez-Montreuil M. Maniez-Montreuil M. Ann Biol Clin (Paris). 1998 Sep-Oct;56(5):563-70. Ann Biol Clin (Paris). 1998. PMID: 9769480 Review. French.
• [Confirmation of the presence in Cuba of human T-cell lymphotropic virus type I using the polymerase chain reaction].

  Rolo Gómez F, De Armas MB, Mato Luis J, Lubián Caballero AL, Díaz Torres H. Rolo Gómez F, et al. Rev Cubana Med Trop. 1997;49(3):204-8. Rev Cubana Med Trop. 1997. PMID: 9685988 Spanish.
• The HTLV tax-like sequences in cutaneous T-cell lymphoma patients.

  Zendri E, Pilotti E, Perez M, Turci M, Pinelli S, Ronzi P, Frontani M, Faraggiana T, De Panfilis G, Casoli C. Zendri E, et al. J Invest Dermatol. 2008 Feb;128(2):489-92. doi: 10.1038/sj.jid.5701034. Epub 2007 Aug 30. J Invest Dermatol. 2008. PMID: 17762859 No abstract available.